Our Products

Our products support the health of patients in the areas of maternal and women's health, anemia management and cancer supportive care. More

Research & Growth

We recognize the immense value of clinical research and are committed to investing in it to expand the body of knowledge in our therapeutic areas and advance potential future health innovations for patients. More

AMAG Corporate Principles

Our company values provide an important framework for who we are and how we operate. AMAG is also committed to a set of corporate principles that guide how we pursue our business goals and deliver on our promise to patients and their families. More

News

Study of Feraheme demonstrates Improvements in Fatigue and Quality Of Life in...

Study of Feraheme demonstrates Improvements in Fatigue and Quality Of Life in Iron Deficiency Anemia Patients

WALTHAM, Mass. December 3, 2018 – AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that research supported by the Company, “Sustained Improvements More

AMAG Pharmaceuticals Awards Four Grants to Further Research in Preterm Birth and...

AMAG Pharmaceuticals Awards Four Grants to Further Research in Preterm Birth and Preeclampsia

WALTHAM, Mass., November 29, 2018 – As part of the company’s annual grant program to support research to reduce preterm birth and preeclampsia and More

Working at AMAG

"I get to wear a lot of different hats in an industry that provides very fast-paced and interesting work along with the opportunity to solve the puzzle of treatments for difficult diseases."

David Knauss
Senior Manager, Regulatory Affairs & Medical Writing